Hepatic adenoma and focal nodular hyperplasia: MR findings with superparamagnetic iron oxide-enhanced MRI

R G Beets-Tan1, J M Van Engelshoven, J W Greve

  • 1Department of Radiology, University Hospital Maastricht, The Netherlands.

Clinical Imaging
|April 29, 1998
PubMed

Insights

Superparamagnetic iron oxide (SPIO) enhanced MRI helps differentiate benign liver lesions like hepatic adenoma and focal nodular hyperplasia (FNH). This study details SPIO-enhanced MRI findings, including previously undescribed hemorrhage in hepatic adenoma.

Area of Science:

  • Radiology
  • Medical Imaging
  • Hepatology

Background:

  • Superparamagnetic iron oxide (SPIO) particles enhance MRI contrast for liver lesion characterization.
  • Differentiating benign liver lesions from malignant tumors is crucial for patient management.
  • Previous studies have explored SPIO-enhanced MRI for liver lesions, but specific findings require further elucidation.

Observation:

  • Two cases involving hepatic adenoma and focal nodular hyperplasia (FNH) are presented.
  • SPIO-enhanced MRI demonstrates iron oxide particle uptake in benign liver lesions.
  • Hemorrhage within a hepatic adenoma following SPIO enhancement is described for the first time.

Findings:

  • SPIO-enhanced MRI allows for the differentiation of benign liver lesions from malignant counterparts.
  • Specific SPIO-enhanced MR features of FNH are illustrated to aid in differential diagnosis.
  • The uptake of SPIO particles by benign lesions is a key diagnostic indicator.

Implications:

  • SPIO-enhanced MRI offers a valuable tool for the differential diagnosis of hepatic adenoma and FNH.
  • This technique can improve diagnostic accuracy and guide treatment decisions for liver lesions.
  • Further research into SPIO-enhanced MRI findings in various liver pathologies is warranted.